The recent study published in the BMJ has revealed a potential link between prolonged use of certain hormone drugs and an increased risk of developing intracranial meningioma, a type of brain tumor. The results showed that prolonged use (a year or more) of medrogestone, medroxyprogesterone acetate injection, and promegestone was associated with an increased risk of intracranial meningioma.
Prolonged Use of Certain Hormone Drugs and Increased Risk of Intracranial Meningioma
The study found that the risk of developing intracranial meningioma was higher among individuals who used these hormone drugs for a year or more. Specifically, the study revealed that:
– Prolonged use (a year or more) of medrogestone, medroxyprogesterone acetate injection, and promegestone was associated with an increased risk of intracranial meningioma.